岐阜大学 · 医学部附属病院 · 准教授

研究キーワードgastric cancer・metastatic colorectal cancer・pancreatic cancer・immune checkpoint therapy・phase two trials・cancer chemotherapy

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment.
• Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
• Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.
• Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept.

• 公式プロフィール